Your browser doesn't support javascript.
loading
Lung fluid clearance in chronic heart failure patients.
Dixon, Dani-Louise; De Pasquale, Carmine G; Lawrence, Mark D; Cavallaro, Elena; Rubino, Vito; Bersten, Andrew D.
Affiliation
  • Dixon DL; Intensive and Critical Care Unit, Flinders Medical Centre, Adelaide, Australia; Department of Critical Care Medicine, Flinders University, Adelaide, Australia. Electronic address: dani.dixon@flinders.edu.au.
  • De Pasquale CG; Cardiac Services, Flinders Medical Centre, Adelaide, Australia; Department of Medicine, Flinders University, Adelaide, Australia.
  • Lawrence MD; Department of Critical Care Medicine, Flinders University, Adelaide, Australia.
  • Cavallaro E; Department of Critical Care Medicine, Flinders University, Adelaide, Australia.
  • Rubino V; Medical Imaging, Flinders Medical Centre, Adelaide, Australia.
  • Bersten AD; Intensive and Critical Care Unit, Flinders Medical Centre, Adelaide, Australia; Department of Critical Care Medicine, Flinders University, Adelaide, Australia.
Int J Cardiol ; 244: 245-247, 2017 Oct 01.
Article in En | MEDLINE | ID: mdl-28625511
Chronic elevation of pulmonary microvascular pressure (Pmv) consistently leads to alveolocapillary barrier thickening and reduction in the filtration coefficient. In animal models of chronic heart failure (CHF) the lung remains dry despite hydrostatic forces. As fluid flux is bi-directional, it has been postulated that an increase in alveolar fluid clearance may facilitate the dry lung when Pmv is chronically elevated. In this study we aimed to examine alveolar fluid clearance in ambulatory patients with CHF secondary to left ventricular (LV) systolic dysfunction compared against non-CHF controls. Lung clearance following aerosol delivery of 99mtechnetium (Tc)-diethyl triaminepentaacetic acid (DTPA) was measured non-invasively by scintigraphy and half time of 99mTc-DTPA clearance (T (1/2)) was calculated by mono-exponential curve fit. Alveolar fluid clearance measured as half time DTPA clearance was significantly faster in CHF patients than controls (P=0.001). This was further defined by NYHA classification. No correlation was found between DTPA clearance and plasma epinephrine, norepinephrine or aldosterone hormone (P>0.05). Our results support an association between increasing alveolar fluid clearance and disease severity in CHF, and the concept of controlled bi-directional fluid flux in CHF associated with increasing Pmv, and represents another defence mechanism of the lung against pulmonary oedema.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Edema / Heart Failure / Lung Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cardiol Year: 2017 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Edema / Heart Failure / Lung Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Cardiol Year: 2017 Type: Article